Eversept Partners’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Eversept Partners’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,327,857	Closed	-$2.93M	–	83
2023 Q2	$2.93M	Buy	1,327,857 +689,383	+108%	+$1.43M	0.25%	53
2023 Q1	$1.62M	Buy	+638,474	New	+$1.26M	0.11%	55

Eversept Partners's PRTK Position: Q3 2023 in Review

Eversept Partners sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 1,327,857 shares — an estimated $2.93M sold.

Eversept Partners first reported a position in PRTK in Q1 2023 and held it in 2 quarters. The position peaked at $2.93M in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Eversept Partners reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Eversept Partners sold 1,327,857 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $2.93M.
Eversept Partners first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2023 and held it in 2 quarters.
Eversept Partners's Paratek Pharmaceuticals, Inc. position peaked at $2.93M in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.